Loading...
healthfitnessmedicine
Kiwi obesity drug wins praise abroad as doubts linger at home
About this Episode
Recent developments from New Zealand reveal a natural supplement that is gaining international recognition for its similarity to the popular weight loss drug, Ozempic. Sarah Kennedy's appetite suppressant, Calocurb, is experiencing explosive growth overseas, while it faces skepticism within its home country.
Ozempic, originally manufactured by Novo Nordisk, is a medication primarily used in the treatment of type 2 diabetes but has gained widespread attention for its significant weight loss benefits. Unlike many other weight-loss drugs, Ozempic operates through a mechanism that regulates insulin and inhibits glucagon, which also helps to reduce appetite. Its efficacy in promoting weight loss has made it a popular choice for those looking to shed pounds.
In contrast, Calocurb, developed in New Zealand, prides itself on being a 'natural' counterpart to Ozempic. It contains Amarasate extract, a compound derived from New Zealand hops that is scientifically demonstrated to trigger the release of 'stop eating' signals in the brain, significantly reducing calorie intake. Just like Ozempic, the core function of Calocurb centers around appetite suppression, but it does so using naturally sourced ingredients.
Despite its booming popularity in international markets, Calocurb has been met with some skepticism domestically. The natural claims and rapid weight loss results have triggered caution among consumers and health professionals alike in New Zealand. The primary concern is the long-term effects and sustainability of its usage, considering the rigorous regulatory standards and extensive clinical testing that pharmaceutical drugs like Ozempic undergo.
The international success of Calocurb, however, cannot be understated. Its reception in global markets indicates a robust demand for weight loss supplements that prefer natural over synthetic routes. While clinical studies have backed its efficacy, further research and user testimonials over time will be key to sustaining its growth and acceptance both domestically and globally.
As obesity and weight management continue to be significant health issues worldwide, the introduction and evolution of products like Calocurb can potentially offer consumers more choices. However, the balance between effectiveness, safety, and natural composition will remain paramount in gaining wider acceptance among health professionals and the broader public.
This content was created in partnership and with the help of Artificial Intelligence AI
Ozempic, originally manufactured by Novo Nordisk, is a medication primarily used in the treatment of type 2 diabetes but has gained widespread attention for its significant weight loss benefits. Unlike many other weight-loss drugs, Ozempic operates through a mechanism that regulates insulin and inhibits glucagon, which also helps to reduce appetite. Its efficacy in promoting weight loss has made it a popular choice for those looking to shed pounds.
In contrast, Calocurb, developed in New Zealand, prides itself on being a 'natural' counterpart to Ozempic. It contains Amarasate extract, a compound derived from New Zealand hops that is scientifically demonstrated to trigger the release of 'stop eating' signals in the brain, significantly reducing calorie intake. Just like Ozempic, the core function of Calocurb centers around appetite suppression, but it does so using naturally sourced ingredients.
Despite its booming popularity in international markets, Calocurb has been met with some skepticism domestically. The natural claims and rapid weight loss results have triggered caution among consumers and health professionals alike in New Zealand. The primary concern is the long-term effects and sustainability of its usage, considering the rigorous regulatory standards and extensive clinical testing that pharmaceutical drugs like Ozempic undergo.
The international success of Calocurb, however, cannot be understated. Its reception in global markets indicates a robust demand for weight loss supplements that prefer natural over synthetic routes. While clinical studies have backed its efficacy, further research and user testimonials over time will be key to sustaining its growth and acceptance both domestically and globally.
As obesity and weight management continue to be significant health issues worldwide, the introduction and evolution of products like Calocurb can potentially offer consumers more choices. However, the balance between effectiveness, safety, and natural composition will remain paramount in gaining wider acceptance among health professionals and the broader public.
This content was created in partnership and with the help of Artificial Intelligence AI
Hosts & Guests
No transcript available for this episode.
